Pricing

Ironwood Pharmaceuticals Inc (IRWD)

followers ·
Sector: HEALTH CARE
Industry: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
CEO: Thomas A. McCourt
Employees: 220
Web site: ironwoodpharma.com
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
617-621-7722
Stock Split History
DateRatio
2019-04-02 1194:1000
All 13F Filers Prior Change Hedge Funds 1 Prior Change
Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation.
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available